Suppr超能文献

使用同时进行的腹部常温区域性灌注的控制性死后循环捐献供者行肺移植:单中心经验。

Lung transplantation from controlled donation after circulatory death using simultaneous abdominal normothermic regional perfusion: A single center experience.

机构信息

Service of Neumology, Lung Transplantation Unit, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

Transplant Coordination Unit & Service of Intensive Care, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.

出版信息

Am J Transplant. 2022 Jul;22(7):1852-1860. doi: 10.1111/ajt.17057. Epub 2022 Apr 18.

Abstract

Despite the benefits of abdominal normothermic regional perfusion (A-NRP) for abdominal grafts in controlled donation after circulatory death (cDCD), there is limited information on the effect of A-NRP on the quality of the cDCD lungs. We aimed to study the effect of A-NRP in lungs obtained from cDCD and its impact on recipients´ outcomes. This is a study comparing outcomes of lung transplants (LT) from cDCD donors (September 2014 to December 2021) obtained using A-NRP as the abdominal preservation method. As controls, all lung recipients transplanted from donors after brain death (DBD) were considered. The primary outcomes were lung recipient 3-month, 1-year, and 5-year survival. A total of 269 LT were performed (60 cDCD and 209 DBD). There was no difference in survival at 3 months (98.3% cDCD vs. 93.7% DBD), 1 year (90.9% vs. 87.2%), and 5 years (68.7% vs. 69%). LT from the cDCD group had a higher rate of primary graft dysfunction grade 3 at 72 h (10% vs. 3.4%; p <  .001). This is the largest experience ever reported with the use of A-NRP combined with lung retrieval in cDCD donors. This combined method is safe for lung grafts presenting short-term survival outcomes equivalent to those transplanted through DBD.

摘要

尽管腹部亚常温区域灌注(A-NRP)对控制下的循环死亡后供体(cDCD)腹部移植物有益,但关于 A-NRP 对 cDCD 肺质量影响的信息有限。我们旨在研究 A-NRP 对从 cDCD 获得的肺的影响及其对受者结局的影响。这是一项比较使用 A-NRP 作为腹部保存方法获得的 cDCD 供体肺移植(LT)与脑死亡(DBD)供体移植的肺受体 3 个月、1 年和 5 年生存率的研究。作为对照,考虑了所有从 DBD 供体移植的肺受体。主要结局是肺受体 3 个月、1 年和 5 年生存率。共进行了 269 例 LT(60 例 cDCD 和 209 例 DBD)。3 个月(98.3% cDCD 与 93.7% DBD)、1 年(90.9% 与 87.2%)和 5 年(68.7% 与 69%)的生存率无差异。cDCD 组在 72 小时原发性移植物功能障碍 3 级的发生率更高(10%与 3.4%;p < 0.001)。这是迄今为止使用 A-NRP 联合肺获取在 cDCD 供体中报告的最大经验。这种联合方法对肺移植物是安全的,短期生存结果与通过 DBD 移植的结果相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验